The challenge the researchers set out to address is a real and persistent one in transfusion medicine. Red blood cells can be stored refrigerated for only a limited window before they lose quality, which is why cryopreservation, freezing cells at ultra-low temperatures, is used to keep rare blood types available for years until a matching patient needs them. The conventional approach relies on glycerol, a chemical that penetrates the cells and prevents the formation of ice crystals, the sharp structures that would otherwise pierce and shred cell membranes during freezing and thawing. Glycerol works, but it comes with a catch: before a frozen unit of blood can be transfused, the glycerol must be washed out of the cells, and that removal step itself inflicts damage on a fraction of the precious cells it was meant to protect.

Enter the tardigrade. When conditions turn lethal, these animals deploy a suite of protective molecules, including a remarkable family of proteins known as CAHS, short for cytosolic abundant heat-soluble proteins. These proteins help tardigrades endure extreme dehydration and freezing by forming protective structures inside their cells. What makes CAHS proteins especially interesting for biotechnology is their unique interaction with trehalose, a naturally occurring sugar that stabilizes cell membranes and proteins. Trehalose is already familiar in other industries; it is commonly used to reduce freezer burn in frozen foods, a testament to its ability to shield biological material from the stresses of low temperatures. Hui Yang, Leming Sun, and their colleagues reasoned that if tardigrades use CAHS proteins and trehalose together to survive the unsurvivable, the same combination might protect mammalian cells in the freezer.

“This study was our first attempt to translate a lesson from an extraordinarily resilient organism into a practical cell-preservation strategy,” explains Sun, one of the corresponding authors of the study. “If further developed, it could make the process simpler after thawing, reduce concerns associated with residual glycerol, and help preserve the quality of stored cells.” That framing captures the spirit of the work: rather than inventing a protective chemistry from scratch, the team reverse-engineered a solution that evolution had already validated in one of nature’s most extreme survivors.

The technical details of the approach reveal careful optimization. Rather than working with the full-length CAHS protein, the researchers determined that a specific section, or motif, of the protein was sufficient to deliver the protective effect they needed. This kind of reduction matters for practical applications, since shorter peptide segments are easier and cheaper to produce, characterize, and quality-control than large, complex proteins. The team combined this CAHS-derived segment with trehalose at low temperature, a step that encourages the sugar to load into the cells, and then plunged the samples into liquid nitrogen for freezing.

What happened at the molecular level during that freeze is the heart of the discovery. The combination of the CAHS motif and trehalose changed the way ice formed and melted within and around the cells, suppressing the ice damage that normally destroys frozen blood. In other words, the tardigrade-derived system did not simply replace glycerol as an antifreeze additive; it actively restructured the freezing process itself, creating a gentler environment for the delicate red blood cell membranes. And when the cells were thawed, the protective cocktail proved easy to remove: a simple wash by centrifugation was enough to clear away the CAHS-trehalose mixture, eliminating the multi-step glycerol removal that burdens the conventional workflow.

The numbers tell a compelling story. Up to 89 percent of mouse red blood cells preserved with the new tardigrade-inspired method recovered fully after freezing and thawing, compared with roughly 82 percent of cells frozen using the standard glycerol protocol. That seven-percentage-point improvement may sound modest, but in the context of a blood supply, where every unit matters and rare types can be desperately hard to match, recovering more usable cells from each frozen unit translates directly into more transfusions for patients. It also means less waste of donated blood, a resource that depends entirely on volunteer donors and cannot be manufactured.

Recovery rates alone, however, are not enough to justify a new clinical approach. Transfused cells must be safe as well as abundant. To test this, the team evaluated whether the cryopreserved blood cells remained biocompatible after being frozen, thawed, and washed. The answer was encouraging on both counts. In a live-animal model, anemic mice that received transfusions of the cryopreserved blood showed significantly improved red blood cell counts and hemoglobin levels, confirming that the thawed cells were not just intact but functionally capable of doing their oxygen-delivery job. Just as importantly, the transfusions did not trigger an inflammatory response, a critical safety signal indicating that the treated cells did not provoke the immune system of the recipients.

The implications reach beyond the blood bank. The researchers hope their work will inform the design of better cryopreservation strategies more broadly, potentially protecting other cell types and tissues that are currently difficult to freeze without heavy losses. They also point toward an even more ambitious goal: protective strategies that could keep blood viable at room temperature, which would transform logistics in regions where maintaining a cold chain, let alone a liquid nitrogen supply, is expensive or impractical. A tardigrade-inspired formulation that guards cells across temperature extremes is a natural starting point for that vision, since the proteins it derives from evolved precisely to bridge the gap between wet and dry, frozen and thawed.

For now, the work stands as a striking example of biomimicry at the molecular scale, a reminder that some of the best engineering solutions have already been debugged by nature over hundreds of millions of years. The study received funding from the National Natural Science Foundation of China, the Guangdong Basic and Applied Basic Research Foundation, and the Natural Science Basic Research Plan in Shaanxi Province of China. From here, translating the mouse results into human blood banking will require further development and validation, but the conceptual leap is complete: a protein motif from an animal that shrugs off the vacuum of space has shown it can help something as ordinary, and as vital, as a bag of donated blood survive the deep freeze. If the tardigrade’s trick continues to perform as it scales, the water bear may soon earn a place in hospitals, quietly keeping rare blood types ready for the patients who need them.

Subject of Research: Tardigrade-derived CAHS proteins for glycerol-free cryopreservation of red blood cells

Article Title: A trick from tardigrades could help human blood withstand freezing

Article References: A trick from tardigrades could help human blood withstand freezing. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: tardigrades, cryopreservation, red blood cells, CAHS proteins, trehalose, glycerol, blood banking, transfusion medicine, ice crystal formation, biomimicry, ACS Applied Materials & Interfaces, anemic mice

The study, published in Plant Cell Reports, combined physiology, transcriptomics, metabolomics, and enzyme assays to trace exactly how exogenous trehalose bolsters salt tolerance in tomato seedlings. The findings reveal that hydrogen sulfide acts as a central mediator in trehalose-induced protection, and that the downstream response funnels through two metabolic routes: the phenylpropanoid pathway, a workhorse of plant defense chemistry, and the less celebrated cyanoamino acid metabolism pathway, which processes cyanogenic compounds. The work offers a clearer mechanistic picture of how two stress-protective agents interact, and it hints at practical strategies for shielding crops from salinity.

Trehalose is no stranger to stress biology. This disaccharide, composed of two glucose units, accumulates in an astonishing range of organisms, from resurrection plants that survive near-total desiccation to yeast cells braving heat and dehydration. In plants, trehalose and its phosphorylated precursor trehalose-6-phosphate serve dual roles as osmoprotectants that stabilize proteins and membranes, and as sugar signals that rewire metabolism during stress. Previous studies had shown that spraying tomato seedlings with trehalose improves their performance under salt stress by modulating reactive oxygen species, photosynthesis, and osmolyte synthesis. Hydrogen sulfide, meanwhile, has shed its reputation as merely a toxic, rotten-egg-smelling gas. Over the past two decades, plant biologists have established that H2S functions as a genuine signaling molecule, regulating seed germination, stomatal closure, and a broad spectrum of abiotic stress responses, often through persulfidation, a chemical modification that alters the activity of target proteins.

What remained unknown was how these two protective agents relate to each other when deployed together. The Guangxi team, led by corresponding author Changxia Li with co-first authors Jin Qi and Zhang Zhang, designed a series of experiments to answer that question. They grew tomato seedlings under salt stress and treated them with trehalose alone, with sodium hydrosulfide (NaHS), a donor of hydrogen sulfide, alone, or with both compounds simultaneously. The physiological results were striking: both treatments significantly alleviated salt-induced growth inhibition, but the combined treatment produced the most pronounced protective effect, suggesting the two agents act in complementary or synergistic ways.

To dissect the direction of the relationship, the researchers turned to pharmacology. They applied validamycin A, an inhibitor of trehalose biosynthesis, and hypotaurine, a chemical scavenger that mops up hydrogen sulfide. The logic was simple but powerful: if removing hydrogen sulfide abolishes trehalose’s benefits, then trehalose must depend on the gas to work. The experiments delivered a clear verdict. The protective effect of trehalose was largely dependent on hydrogen sulfide, because scavenging the gas with hypotaurine substantially undermined trehalose-induced salt tolerance. In contrast, the efficacy of the NaHS donor was independent of trehalose, indicating a one-directional dependency: trehalose needs hydrogen sulfide, but hydrogen sulfide does not need trehalose. The authors are careful to note the limits of this interpretation. Their data mainly support a requirement for H2S in trehalose action rather than demonstrating that hydrogen sulfide alone is sufficient to reproduce the full trehalose response, and they call for further functional analyses to clarify the precise hierarchy between the two signals.

With the physiological dependency established, the team moved to the molecular level using RNA sequencing. The transcriptomic analysis showed that trehalose modulates the salt stress response of tomato seedlings at the transcriptional level via hydrogen sulfide, and it pinpointed phenylalanine biosynthesis as a core metabolic target. Phenylalanine is the gateway amino acid for the phenylpropanoid pathway, one of the most important specialized metabolic networks in plants. From phenylalanine, plants build an enormous arsenal of compounds, including lignin, which reinforces cell walls and forms apoplastic barriers against ion intrusion; flavonoids and anthocyanins, which act as antioxidants; and a variety of phenolic compounds that buffer oxidative damage. The second pathway flagged by the analysis was cyanoamino acid metabolism, the route that produces and processes cyanogenic glycosides, nitrogen-containing defense metabolites derived from amino acids.

The metabolomic data reinforced the transcriptomic picture. Compared with seedlings receiving salt plus trehalose, those that also received the hydrogen sulfide scavenger hypotaurine showed significantly reversed accumulation of protective metabolites. In the phenylpropanoid pathway, the compounds p-coumaryl alcohol and coniferyl alcohol, both monolignols that feed into lignin biosynthesis, accumulated in response to trehalose but dropped back when hydrogen sulfide was removed. In the cyanoamino acid pathway, the cyanogenic glycosides amygdalin and prunasin, compounds more famous for their roles in almond and stone fruit bitterness, followed the same pattern. This is a notable finding because it implicates a pathway usually discussed in the context of herbivore defense in abiotic stress tolerance, adding to a growing body of evidence that cyanogenic metabolism contributes to how plants cope with environmental challenges.

The enzymatic and gene expression data tied the whole story together. The salt plus trehalose treatment significantly elevated the activities of key enzymes in the phenylpropanoid biosynthesis pathway, including 4-coumarate-CoA ligase (4CL), caffeoyl-CoA O-methyltransferase (CCoAOMT), and peroxidase (POD), as well as enzymes in the cyanoamino acid metabolism pathway, namely mandelonitrile lyase (MDL) and beta-glucosidase (bglX). Consistent with these biochemical changes, the transcript levels of the corresponding encoding genes, including 4CL1, CCoAOMT, POD9, POD43, MDL3, and bglX1, were significantly upregulated. When hypotaurine was added to scavenge hydrogen sulfide, the trehalose-induced enhancement of both enzyme activities and gene expression was significantly reversed. At the molecular level, this confirms that hydrogen sulfide sits upstream of these metabolic changes, serving as a central mediator through which trehalose exerts its protective influence during salt stress.

Why does this matter beyond the laboratory? Salinity stress imposes a double burden on plants: excess sodium ions are toxic, and the osmotic stress they create makes it harder for roots to take up water. Plants respond with a suite of defenses, including osmolyte accumulation, ion homeostasis, and antioxidant systems that neutralize the reactive oxygen species generated under stress. The phenylpropanoid pathway sits at the heart of several of these defenses, supplying lignin for physical barriers and phenolic compounds for antioxidant protection. If trehalose triggers these defenses only through hydrogen sulfide, then breeding or engineering approaches might target the signaling relay itself, for instance by enhancing H2S production capacity or persulfidation of key regulatory proteins, to amplify a crop’s intrinsic stress response. Alternatively, combined field treatments of trehalose and hydrogen sulfide donors could be optimized to exploit the synergy observed in seedlings, though translating greenhouse pharmacology to open-field agriculture always demands careful validation.

The study also enriches a rapidly expanding literature on hydrogen sulfide as a master regulator of plant stress resilience. Recent work has shown that H2S promotes lateral root formation in peach through persulfidation of the SnRK1α kinase, balances hydrogen sulfide and hydrogen cyanide homeostasis in Arabidopsis under osmotic stress, and modulates phenolic metabolism to alleviate salt stress in tomato. The Guangxi findings slot neatly into this picture while adding a new layer: they position trehalose, a sugar signal, upstream of the gas, and they extend the downstream reach of the gas into cyanoamino acid metabolism, a pathway rarely invoked in salt tolerance research. The authors acknowledge that much remains to be resolved, particularly whether hydrogen sulfide alone can reproduce the complete trehalose response and what the precise hierarchical relationship between the two signals looks like under field conditions. But the core message is already compelling: in salt-stressed tomato seedlings, a protective sugar whispers its instructions through a stinky gas, and the plant listens by building stronger walls and richer chemistry. For a crop that feeds billions and a planet whose farmland grows saltier by the season, that conversation is worth every effort to understand and, ultimately, to harness.

Subject of Research: Hydrogen sulfide-dependent trehalose signaling that enhances salt tolerance in tomato seedlings through phenylpropanoid and cyanoamino acid metabolism

Article Title: H2S-dependent trehalose-induced salt tolerance in tomato involves phenylpropanoid and cyanoamino acid pathways

Article References: Qi, J., Zhang, Z., Li, S., Su, J., Tian, Y., Yu, W., & Li, C. (2026). H2S-dependent trehalose-induced salt tolerance in tomato involves phenylpropanoid and cyanoamino acid pathways. Plant Cell Reports, 45(10), Article 283. https://doi.org/10.1007/s00299-026-03969-5

Image Credits: AI Generated

DOI: 10.1007/s00299-026-03969-5

Keywords: trehalose, hydrogen sulfide, salt stress, tomato, phenylpropanoid pathway, cyanoamino acid metabolism, transcriptomics, plant stress signaling, sodium hydrosulfide, hypotaurine, antioxidant defense, Plant Cell Reports

A glucose unit, for example, carries multiple hydroxyl groups of similar reactivity. If a chemist wants to attach a polymerizable handle to one specific position on the sugar ring, the other hydroxyls must typically be protected with temporary blocking groups, modified, and then deprotected through a sequence of steps that adds cost, time, and waste. This multistep protection–deprotection strategy has been a persistent bottleneck in glycopolymer synthesis, limiting how quickly new carbohydrate-based materials can be designed and tested. A research collaboration in Japan now reports a way around this obstacle, using an unusual microbial metabolite whose structure solves the selectivity problem by design rather than by brute-force chemistry.

The team, led by Professor Koji Matsuoka of the Graduate School of Science and Engineering at Saitama University together with researchers at the Institute of Microbial Chemistry, known as BIKAKEN, turned its attention to 4-trehalosamine. This molecule is a close analog of trehalose, the familiar disaccharide that many organisms use to survive drying and freezing. In 4-trehalosamine, one of the hydroxyl groups of trehalose is replaced by an amino group at the C4 position of the sugar. That single substitution changes the chemical landscape dramatically: instead of a forest of nearly identical hydroxyls, the molecule carries one amino group at a defined site, and amino groups are far more reactive and easier to modify selectively than hydroxyls.

Previous studies had already established several properties that made 4-trehalosamine an intriguing candidate for materials chemistry. It resists degradation by mammalian trehalase, the enzyme that rapidly cleaves ordinary trehalose in the human body, so it is biologically stable. It can be produced by microbial fermentation, offering a bio-based supply route. And, crucially, its amino group can be modified readily and selectively. The Saitama and BIKAKEN team reasoned that this combination of stability, fermentative production, and built-in chemical orthogonality could make 4-trehalosamine not just a curiosity of microbial metabolism but a versatile platform molecule for constructing new functional materials.

To test that idea, the researchers converted the C4 amino group into a polymerizable acrylamide functionality, producing a sugar-derived monomer that could be fed into standard polymerization chemistry. Acrylamide polymerization is one of the workhorse reactions of water-soluble polymer science, so anchoring the trehalose analog to an acrylamide backbone was a strategically elegant choice. The team then carried out polymerization reactions, including copolymerization with ordinary acrylamide, and showed that by varying the ratio of the sugar monomer to the comonomer they could prepare water-soluble polyacrylamides containing adjustable amounts of 4-trehalosamine-derived units. In other words, the sugar content of the final polymer was not fixed by the chemistry but became a tunable design parameter.

The significance of this control should not be understated. In conventional glycopolymer synthesis, achieving a defined sugar loading often requires careful monomer design, multiple protecting-group manipulations, and sometimes low-yielding coupling chemistry. By exploiting the naturally occurring amino group of 4-trehalosamine as a chemical handle, the researchers sidestepped the need to discriminate among the sugar’s many hydroxyl groups altogether. The position of the polymerizable group is dictated by the biosynthesis of the metabolite itself, which means the selectivity problem is solved before the chemist ever enters the laboratory. The result is a shorter, more direct synthetic route from a fermentation product to a composition-tunable glycopolymer.

The study, entitled “A 4-Trehalosamine-Derived Acrylamide Monomer: Synthesis and Preparation of Composition-Tunable Water-Soluble Polyacrylamides,” was made available online in the journal Carbohydrate Research on September 19, 2026. Professor Matsuoka summarized the core insight in a statement accompanying the release: “The amino group of 4-trehalosamine provides a unique handle for selective chemical modification. By converting it into a polymerizable unit, we established a straightforward route to water-soluble glycopolymers with controllable sugar contents.” The phrasing captures why the approach is generically useful rather than a one-off synthesis: the handle is intrinsic to the molecule, so the same logic could in principle be extended to other polymer architectures beyond polyacrylamides.

What might such materials be used for? The authors point toward applications in which hydration, stabilization, molecular interactions, or interfaces matter. Trehalose itself is famous as a bioprotective agent, stabilizing proteins, membranes, and even whole cells during drying and freezing, so polymers bearing trehalosamine units could plausibly serve as stabilizing excipients or protective coatings, although the team is careful to note that such uses remain to be demonstrated. More broadly, water-soluble glycopolymers are studied as rheology modifiers, biomaterials, and components of drug delivery systems, and a fermentation-derived monomer with tunable incorporation could give materials scientists a new lever for optimizing properties such as water affinity, biocompatibility, and interaction with biological surfaces.

The researchers are equally candid about what remains to be done. The physicochemical and biological properties of each individual polymer must be evaluated before any application can be pursued, and questions of manufacturing scale and safety will need dedicated study. Fermentation-derived supply is promising from a sustainability standpoint, but translating a laboratory-scale monomer synthesis into an industrial process involves yield optimization, purification, and regulatory considerations that go well beyond the present work. The team frames the current results as the establishment of a synthetic platform rather than the delivery of a finished material—a foundation on which systematic structure–property studies can now be built.

Professor Matsuoka’s forward-looking comments underline that ambition. “We anticipate that this platform will facilitate the rational design of carbohydrate-containing polymers for biotechnology and advanced functional materials,” he said, adding that because 4-trehalosamine can be produced biologically and selectively modified, it may help connect fermentation-derived molecules with functional polymer materials. “As interest in bio-based materials continues to grow, this approach may provide new opportunities for developing sustainable functional polymers.” In an era when chemists are increasingly asked to source feedstocks renewably and to streamline synthetic routes, a sugar analog that arrives from a fermenter with its reactive handle already installed—and that can be converted into water-soluble polymers with designer sugar contents in a few well-precedented steps—offers exactly the kind of convergence between biotechnology and polymer science that the field has been seeking.

Subject of Research: Synthesis of 4-trehalosamine-derived acrylamide monomers for composition-tunable water-soluble glycopolymers

Article Title: Trehalose analog provides a new platform for designing water-soluble glycopolymers

Article References: Trehalose analog provides a new platform for designing water-soluble glycopolymers. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: 4-trehalosamine, trehalose, glycopolymers, polyacrylamide, carbohydrate chemistry, water-soluble polymers, acrylamide monomer, fermentation, biobased materials, Saitama University, selective modification, biotechnology

The problem begins with a paradox inherent to phages themselves. These viruses are essentially nucleic acids wrapped in protein coats, decorated with tail fibers and baseplate structures that must remain precisely folded to recognize and inject their genetic payload into bacterial hosts. Unlike small-molecule drugs, which can often tolerate considerable environmental variation, phage infectivity depends on conformational integrity at the nanometer scale. A tail fiber that unfolds, a capsid that cracks, or a protein subunit that detaches can render a particle noninfectious even though the genetic material remains fully intact. Liquid formulations, which are preferable for many clinical settings because they avoid the stresses and costs of lyophilization, expose particles continuously to the surfaces of their containers, to each other, and to solution conditions that shift subtly over time.

Surface adsorption is the first and often the fastest loss mechanism. Phage particles, like many proteins, carry a mosaic of charged and hydrophobic patches that attract them to interfaces. Glass vials, plastic syringes, rubber stoppers and tubing all present surfaces to which virions can adhere, sometimes irreversibly. For low-concentration preparations, intended for pediatric dosing or for phages that are difficult to propagate to high titers, even a small fraction of adsorbed particles can translate into a clinically significant loss of dose. The study underscores that adsorption is not uniform across container materials: hydrophobic polymers tend to sequester particles more aggressively than borosilicate glass, but glass introduces its own risks through leached metal ions and alkaline surface chemistry. The authors emphasize that adsorption must be evaluated for every combination of phage, container and buffer, because a formulation that works beautifully for one phage type may fail entirely for another.

The second threat, aggregation, arises when particles collide and stick together, forming dimers, larger clusters and eventually visible precipitates. Aggregation is driven by electrostatic attraction between oppositely charged regions of adjacent particles, by hydrophobic interactions between exposed protein patches, and by the removal of stabilizing hydration shells during freezing and thawing or during shifts in ionic strength. Aggregated phages are problematic on multiple levels. Aggregates sediment during storage, creating heterogeneous dosing; they are cleared more rapidly from the bloodstream after injection; and they can trigger immune responses or exceed particulate limits set by pharmacopoeial standards for injectable products. Crucially, aggregation and infectivity loss are not always correlated in simple ways, which means that turbidity measurements or particle counts alone cannot substitute for plaque assays when assessing formulation quality.

The third mechanism, structural degradation, is the slowest but perhaps most insidious. Over weeks and months in liquid storage, capsid proteins can undergo deamidation, oxidation and backbone cleavage, while tail structures can gradually lose the precise geometry required for host recognition. Temperature accelerates these processes dramatically, which is why cold-chain dependence has been such a burden on phage therapy programs. The research highlights that structural degradation is often detected only through functional assays: a formulation may look perfectly clear and show normal particle counts by electron microscopy, yet exhibit a steady decline in plaque-forming units as more and more particles lose their ability to infect. This decoupling of appearance from activity is a central argument for rigorous, infectivity-based stability testing.

Against this backdrop, the study evaluates the protective roles of specific classes of excipients, the pharmaceutically accepted, nonactive ingredients that surround the phage in the final product. Sugars and sugar alcohols, including sucrose, trehalose and mannitol, emerge as foundational stabilizers. These molecules act through preferential exclusion, a thermodynamic effect in which the sugar is excluded from the surface of the protein, effectively making the folded state energetically favorable and discouraging both unfolding and aggregation. Trehalose in particular has a long history in the stabilization of biological drugs and vaccines, and the findings reinforce its value for phages, where it buffers particles against osmotic shocks and reduces interfacial stress. Polysorbates and other nonionic surfactants occupy a complementary niche: by adsorbing competitively to container surfaces and air-liquid interfaces, they deny phage particles access to the very interfaces where adsorption and surface-induced denaturation occur. Even low concentrations of surfactant can dramatically reduce the fraction of virions lost to a plastic syringe barrel.

Amino acids and buffering agents form the third pillar of the protection strategy. Arginine, glycine and histidine appear repeatedly in biologics formulations because they disrupt electrostatic attractions that drive aggregation, while histidine buffer offers mild pH control near neutrality, where most phages are comfortable. Plasma proteins and serum albumin, historically used as catch-all stabilizers in early phage work, are discussed in the context of modern pharmaceutical expectations: although effective, animal-derived proteins raise regulatory and supply concerns, pushing formulators toward chemically defined alternatives. Salts deserve careful handling, the authors note, because ionic strength simultaneously affects electrostatic repulsion between particles, adsorption to charged surfaces and the osmotic environment of the capsid; there is no universally optimal salt concentration, and each phage-buffer-container system must be characterized empirically.

Perhaps the most practically important message of the work is that excipient effects are context-dependent and phage-specific. A tailed, contractile Myoviridae-like phage with a large, complex capsid responds differently to stress than a small, robust Podoviridae-like particle. The study therefore advocates a structured development workflow: characterize the phage’s isoelectric point and hydrodynamic behavior, screen a panel of excipient candidates across relevant pH ranges, stress-test the leading candidates with accelerated temperature challenges, and validate the winners under real storage conditions in the intended container closure system. Analytical tools discussed in the article include plaque assays for infectivity, dynamic light scattering and nanoparticle tracking for aggregation, electron microscopy for morphological integrity, and differential scanning fluorimetry or similar methods for probing thermal stability. Combining these orthogonal readouts, rather than relying on any single metric, gives formulators the confidence that a liquid product will remain potent throughout its shelf life.

The implications for the phage therapy field are considerable. Liquid formulations stored at standard refrigeration temperatures, or even at room temperature in optimized compositions, would remove one of the most burdensome logistics constraints on clinical deployment, particularly in regions where deep-freeze distribution is unreliable. Standardized, excipient-protected formulations would also simplify regulatory pathways, since regulators can evaluate excipient safety profiles that are already well established for other biologics. As phage products progress from bespoke compassionate-use preparations toward licensed medicines, the kind of systematic formulation science presented in this study will be indispensable. It transforms the stabilization of phages from a craft of trial and error into a rational engineering discipline, giving the next generation of antiviral antibacterials a fighting chance to arrive intact, potent and ready at the patient’s bedside.

Subject of Research: Use of pharmaceutical excipients to stabilize bacteriophages in liquid formulations by preventing surface adsorption, aggregation and structural degradation.

Article Title: Investigating the role of excipients in mitigating surface adsorption, aggregation and structural degradation in liquid phage formulations

Article References: Siafakas, E., Duong, H. T. T., & Iredell, J. R. (2026). Investigating the role of excipients in mitigating surface adsorption, aggregation and structural degradation in liquid phage formulations. npj Viruses. https://doi.org/10.1038/s44298-026-00233-1

Image Credits: AI Generated

DOI: 10.1038/s44298-026-00233-1

Keywords: bacteriophage, phage therapy, liquid formulation, excipients, trehalose, polysorbate, surface adsorption, aggregation, capsid stability, biologics formulation, antibiotic resistance, npj Viruses